Supraorbital nerve stimulation Cefaly Device - FDA Approved for migraine prevention (also being investigated as acute therapy)

Similar documents
DISCLOSURES FUNCTIONS OF THE HYPOTHALAMUS

Headache: Using Neuromodulation as Therapy

HEADACHE PATHOPHYSIOLOGY

Embriologically, The head is formed from the first two cervical segments (except the mandible, which is formed by the third). The first and second

Neuromodulation in Dravet Syndrome. Eric BJ Segal, MD Director of Pediatric Epilepsy Northeast Regional Epilepsy Group Hackensack, New Jersey

Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache

Clinical Commissioning Policy Statement: Sphenopalatine Ganglion Stimulation for Refractory Chronic Cluster Headache (Adults)

What is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

General Sensory Pathways of the Face Area, Taste Pathways and Hearing Pathways

HEADACHE & FACIAL PAIN SECTION. Review Article Neurostimulation for Treatment of Migraine and Cluster Headache

Medical Policy. Description/Scope. Position Statement. Rationale

PFO Closure is a Therapy for Migraine PRO

Faculty Disclosures. Learning Objectives

Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine

Neurostimulation 2016

Mark W. Green, MD, FAAN

Migraine Research Update Clinical and Scientific Highlights. David W. Dodick M.D. Professor Department of Neurology Mayo Clinic Phoenix Arizona

A New Era of Migraine Management: The Challenging Landscape in Prevention

Teresa Jacobson Kimberley, PhD, PT

David W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

Corporate Medical Policy

Some Research and Clinical Evidence in support of Treating Cervicogenic Headaches by Massage Therapy

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

ISSN doi: /head VC 2015 American Headache Society Published by Wiley Periodicals, Inc. Vagus Nerve Stimulation and Headache

Greg Book. September 25, 2007 Olin Neuropsychiatry Research Center

Neuromodulation Approaches to Treatment Resistant Depression

ACUTE TREATMENT FOR MIGRAINE. Cristina Tassorelli

V1-ophthalmic. V2-maxillary. V3-mandibular. motor

Specific Objectives A. Topics to be lectured and discussed at the plenary sessions

historical perspective 78 outcomes 81 rationale 78 technique 79 81

Migraine - whats on the horizon

Migraine Pathophysiology. Robert E. Shapiro, MD, PhD

The main features of the TACs:

Organization of The Nervous System PROF. MOUSAED ALFAYEZ & DR. SANAA ALSHAARAWY

Corporate Medical Policy

The Role of Allergies and Sinus Disorders in Headache & Facial Pain

Seizure: the clinical manifestation of an abnormal and excessive excitation and synchronization of a population of cortical

Organization of The Nervous System PROF. SAEED ABUEL MAKAREM

Technologies and architectures" Stimulator, electrodes, system flexibility, reliability, security, etc."

Neuromodulation in Epilepsy. Frederick Langendorf,, MD Department of Neurology Univ of MN and Hennepin Co Medical Center June 4, 2007

The neurvous system senses, interprets, and responds to changes in the environment. Two types of cells makes this possible:

Neuromodulation of chronic headaches: position statement from the European Headache Federation

lecture #2 Done by : Tyma'a Al-zaben

Chapter 17 Nervous System

EE 4BD4 Lecture 20. Therapeutic Stimulation

Original Policy Date

Laboratory Manual for Comparative Anatomy and Physiology Figure 15.1 Transparency Master 114

florida child neurology

Chapter 12b. Overview

rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies

Migraine Treatment What you need to know

MEDICAL POLICY I. POLICY II. PRODUCT VARIATIONS TOP III. DESCRIPTION/BACKGROUND POLICY TITLE SPHENOPALATINE GANGLION BLOCK POLICY NUMBER MP-4.

patients and family NEMOS for treatment of drug-resistant epilepsy

The Effect of Bilateral Block of Greater Occipital Nerve on Chronic Migraine

Sphenopalatine Ganglion Stimulation in Neurovascular Headaches

Primary Headache Prevalence % (95% CI) Migraine without aura 9 (7-9) Migraine with aura 6 (5-8)

Stimulation Ranges, Usage Ranges, and. Paresthesia Mapping During Occipital Nerve Stimulation. Introduction ORIGINAL ARTICLE ABSTRACT

Neuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine

MD, FA F ANS N, FA F C A S

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

PAIN MANAGEMENT in the CANINE PATIENT

Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

UCNS Course A Review of ICHD-3b

1. Processes nutrients and provides energy for the neuron to function; contains the cell's nucleus; also called the soma.

Functional components

Human Anatomy. Autonomic Nervous System

Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20

Occipital Nerve Stimulation Corporate Medical Policy

Electrostimulation Part 3: Bladder dysfunctions

Dubai Standards of Care (Migraine)

GBM8320 Dispositifs Médicaux Intelligents. Electrostimulation. Part 3: Bladder dysfunctions

Disclosures. Objectives 6/2/2017

CHAPTER 13&14: The Central Nervous System. Anatomy of the CNS

Cerebral hemisphere. Parietal Frontal Occipital Temporal

Photophobia and autonomic responses to facial pain in migraine

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Trigeminal Autonomic Cephalalgias. Disclosures. Objectives 6/20/2018. Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018

Peripheral Nerve S-mula-on

NERVOUS SYSTEM ANATOMY

Comparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine

Pain Pathways. Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH

NERVOUS SYSTEM ANATOMY

Chapter 9. Nervous System

Policy #: 411 Latest Review Date: January 2014

The biochemical origin of pain: The origin of all pain is inflammation and the inflammatory response: Inflammatory profile of pain syndromes

Nervous System and Senses Objectives

Occipital Nerve Stimulation with the Bion Microstimulator for the Treatment of Medically Refractory Chronic Cluster Headache

ANAT2010. Concepts of Neuroanatomy (II) S2 2018

A sensitised Headache Hub: the real cause of your Headaches and Migraines

INTEROFFICE MEMORANDUM. TO: Professor K. LaGrandeur FROM: SUBJECT: Audience Analysis for project 4 DATE: 12/17/06

Pain teaching. Muhammad Laklouk

Innovations In Neuromodulation. Maged Guirguis, MD Director Of Research Pain Management

Virtually everyone has experienced pain in one

Affiliation: 1- Departments of Anesthesiology/ Pain Management and Neurology, UCSF School of Medicine 2- Thrive Clinic, LLC, Santa Rosa, CA

Clinical Policy: Vagus Nerve Stimulation

Transcription:

NEUROSTIMULATION/NEUROMODULATION UPDATE Meyer and Renee Luskin Andrew Charles, M.D. Professor Luskin Chair in Migraine and Headache Studies Director, UCLA Goldberg Migraine Program David Geffen School of Medicine at UCLA

DISCLOSURES Amgen Consultant Eli Lilly Consultant eneura Medical Advisory di Board Kimberly Clark Consultant St. Jude Medical Clinical trial steering committee Takeda Research Grant Support Trevena Consultant

NEUROSTIMULATION/NEUROMODULATION APPROACHES Supraorbital nerve stimulation Cefaly Device - FDA Approved for migraine prevention (also being investigated as acute therapy) Transcranial magnetic stimulation Spring TMS Device FDA Approved for acute therapy of migraine with aura Spenopalatine ganglion stimulation initially iti investigated t as acute therapy for cluster headache, now being investigated as preventive therapy Vagal nerve stimulation Initially investigated as acute therapy for migraine and cluster, now being studied as preventive therapy

General Concepts of Neurostimulation for Headache Goal is to use peripheral stimulation to provide input to both peripheral and central sites that are involved in headache The fact that input peripheral input may modulate migraine DOES NOT necessarily indicate that there is any pathology at the site of input? Inhibitory or excitatory May depend on frequency, amplitude, other characteristics i of stimulus

PAIN PATHWAYS IN MIGRAINE Meningeal blood vessel Dura Pain Matrix Thalamus Trigeminal ganglion Supraorbital Nerve Peri aqueductal gray Trigeminal cervical complex Upper cervical nerve roots

Upper Neck and Head Pain are Referred to the Same Neurons in the Lower Brainstem Supratentorial dura mater Electrical stimulation Greater occipital nerve Recording electrode Thalamus Trigeminal cervical complex Bartsch T, Goadsby PJ. Cur Pain Headache Rep 2003;7:371-376 376

SUPRAORBITAL NERVE STIMULATION Rationale: Supraorbital nerves are branches of V1 that provide input into central lti trigeminal i nociceptive pathways Many migraine patients experience pain in sensory distribution of these nerves Supraorbital nerve blocks are anecdotally helpful in some patients with migraine Nerve stimulation may relief by stimulation of sensory fibers leading to pain gating, or may cause release of endogenous opioids 1.Ashkenazi A, et al. Peripheral nerve blocks and trigger point injections in headache management a systematic review and suggestions for future research. Headache 2010; 50: 943 52. 2.Reed KL, et al. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia 2010; 30: 260 71.

Randomized, sham-controlled study (sham control stimulation with reduced pulse width, frequency, intensity) 67 patients randomized Primary outcome migraine days per month, 50% responder rate

2573 patients who rented Cefaly were surveyed 2313 who used triptans as acute therapy were selected AE reporting on all patients -Discomfort with use of device causing reduced use (1.25%) -Sleepiness during session -Headache after session -Local skin irritation At end of 40 day rental period: -1077 (46.6%) were not satisfied and returned device Of these, use was 48% of recommended time -1236 (53.4%) were satisfied and purchased device

Transcranial Magnetic Stimulation Rationale: Cortical hyperexcitability may be an mechanism of migraine Transcranial magnetic stimulation can modulate the excitability of the cortex TMS can inhibit cortical spreading depression in animal models Repetitive TMS is now FDA approved for treatment of medication refractory depression (10 Hzstimulation of leftdorsolateral prefrontal cortex)

Volume 9, Issue 4, Pages 373-380, April 2010-267 patients intially enrolled, 201 patients randomized -Treatment during aura with 2 pulses -Primary outcome pain free response at 2 hours

119/164 patients reported reduction in acute medication use, average 8.5 +/- 7.7 days reduction

Rationale: Sphenopalatine Ganglion Stimulation SPG is major extracranial parasympathetic ganglion of the head and is involved in cranial autonomic symptoms of primary headaches SPG block is helpful in some patients with primary headache disorders including migraineand and cluster headache SPG stimulation may interrupt parasympathetic outflow to inhibit pain and autonomic symptoms SPG stimulation may modulate sensory processing in the trigeminalnucleus nucleus caudalis

32 patients enrolled, 28 completed randomized period Each cluster attack treated t with full, subperception, or sham stimulation Pain relief and adverse events recorded at 15 minute time intervals Cluster attack frequency also recorded

Significant Adverse Effects Sensory disturbances (localized loss of sensation, hypoesthesia, paresthesia, dysesthesia, allodynia) 81%, resolved with time in 58% Pain (face, cheek, gum, etc.) 38%, resolved in 100% Tooth pain/sensitivity, swelling, trismus,headache More frequent attacks and side switching switching reported

Rationale: Vagal Nerve Stimulation The vagus nerve innervates multiple anatomical structures potentially involved in migraine Branches of cervical nerves innervating the dura may travel withthe the vagus nerve VNS with implanted stimulators found to be effective as acute therapy for migraine and cluster headache VNS reduces allodynia and glutamate release in response to inflammatory soup applied to dura in rats Mauskop. Vagus nerve e stimulation relieves es chronic refractory migraine raineand and cluster headache. Cephalalgia,25:82 86. 86. 2005 Oshinsky et al., Noninvasive vagus nerve stimulation as treatment for trigeminal allodynia. Pain,, 2014

27 patients, 80 attacks All attacks : Moderate to severe pain at baseline 12/54 (22%) pain free at 2 hours, 23/54 (43%) pain relief at 2 hours; Mild pain at baseline 10/26 (38%) pain free at 2 hours; Relevant adverse effects neck twitching (1), raspy voice (1)

Follow up Studies nvns for Prevention of Headache -59 patients enrolled, 49 completed protocol ->15 days of headache per month for previous 3 months -3treatments t t per day 290 second administrations per treatment

Caloric Vestibular Stimulation Warm/cold stimulation of external ear canal with varying controllable waveforms Rationale is that vestibular pathways represent targets for neuromodulation in migraine Data presented at this meeting

COMMON THEMES WITH NEUROSTIMULATION/NEUROMODULATION Multiple stimulation parameters: Amplitude, duration, frequency of stimulation Overlap betweenacute and preventive effects Anatomical targets/mechanisms of action may be broader or different than those originally proposed Further rigorous studies are needed